Diagnosis of abnormal blood conditions based on polymorphisms in the glycoprotein vi gene
CA 2525646 A1 · Owner: Cambridge Enterprise Limited · Inventors: Smethurst, Peter Alexander; Ouwehand, Willem; Farndale, Richard Willam
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of diagnosis of abnormal blood conditions associated with an increased risk of bleeding are described. Subjects homozygous or heterozygous for the GPVIb allele are at considered to be at increased risk of bleeding. Kits for carrying out the methods of diagnosis, and use of the methods and kits for determining the GPVI allelotype of subjects in need of surgery with a low , platelet count, with an acquired bleeding disorder on blood thinning drugs, or of blood donors is also described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 22, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 22, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 22, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.